Kiromic Biopharma, Inc. Operating Income
Kiromic Biopharma, Inc. reported Operating Income of -$23.77 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-14.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2025-02-14
- Kiromic Biopharma, Inc. operating income (loss) for the quarter ending 2024-12-31 was -$5.71M.
- Kiromic Biopharma, Inc. operating income (loss) for the quarter ending 2024-09-30 was -$6.60M.
- Kiromic Biopharma, Inc. operating income (loss) for the quarter ending 2024-06-30 was -$6.35M.
- Kiromic Biopharma, Inc. operating income (loss) for the quarter ending 2024-03-31 was -$5.11M.
- Kiromic Biopharma, Inc. operating income (loss) for fiscal 2024 was -$23.77M.
- Kiromic Biopharma, Inc. operating income (loss) for fiscal 2023 was -$19.94M.
- Kiromic Biopharma, Inc. operating income (loss) for fiscal 2022 was -$31.11M.
- Kiromic Biopharma, Inc. operating income (loss) for fiscal 2021 was -$25.74M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | -$5.71M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | -$12.31M derived: sum of 2 quarters · filed 2025-02-14 | -$18.66M derived: sum of 3 quarters · filed 2025-02-14 | -$23.77M 10-K · filed 2025-02-14 | ||||
| 2024-09-30 | -$6.60M 10-Q · filed 2024-11-08 | -$12.96M derived: sum of 2 quarters · filed 2024-11-08 | -$18.07M 10-Q · filed 2024-11-08 | -$23.39M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2024-06-30 | -$6.35M 10-Q · filed 2024-08-09 | -$11.47M 10-Q · filed 2024-08-09 | -$16.78M derived: sum of 3 quarters · filed 2025-02-14 | -$22.34M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2024-03-31 | -$5.11M 10-Q · filed 2024-05-10 | -$10.43M derived: sum of 2 quarters · filed 2025-02-14 | -$15.98M derived: sum of 3 quarters · filed 2025-02-14 | -$20.27M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-12-31 | -$5.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | -$10.87M derived: sum of 2 quarters · filed 2025-02-14 | -$15.16M derived: sum of 3 quarters · filed 2025-02-14 | -$19.94M 10-K · filed 2025-02-14 | -$19.94M 10-K · filed 2024-03-19 | |||
| 2023-09-30 | -$5.55M 10-Q · filed 2024-11-08 | -$5.55M 10-Q · filed 2023-11-14 | -$9.85M derived: sum of 2 quarters · filed 2024-11-08 | -$14.62M 10-Q · filed 2024-11-08 | -$14.62M 10-Q · filed 2023-11-14 | -$21.54M derived: sum of 4 quarters · filed 2024-11-08 | ||
| 2023-06-30 | -$4.29M 10-Q · filed 2024-08-09 | -$4.29M 10-Q · filed 2023-08-14 | -$9.07M 10-Q · filed 2024-08-09 | -$9.07M 10-Q · filed 2023-08-14 | -$15.99M derived: sum of 3 quarters · filed 2024-08-09 | -$24.39M derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | -$4.78M 10-Q · filed 2024-05-10 | -$4.78M 10-Q · filed 2023-05-15 | -$11.70M derived: sum of 2 quarters · filed 2024-05-10 | -$20.09M derived: sum of 3 quarters · filed 2024-05-10 | -$28.53M derived: sum of 4 quarters · filed 2024-05-10 | |||
| 2022-12-31 | -$6.92M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$15.32M derived: sum of 2 quarters · filed 2024-03-19 | -$23.75M derived: sum of 3 quarters · filed 2024-03-19 | -$31.11M 10-K · filed 2024-03-19 | ||||
| 2022-09-30 | -$8.40M 10-Q · filed 2023-11-14 | -$16.83M derived: sum of 2 quarters · filed 2023-11-14 | -$24.19M 10-Q · filed 2023-11-14 | -$34.86M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$8.43M 10-Q · filed 2023-08-14 | -$15.80M 10-Q · filed 2023-08-14 | -$26.46M derived: sum of 3 quarters · filed 2023-08-14 | -$32.60M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$7.37M 10-Q · filed 2023-05-15 | -$18.03M derived: sum of 2 quarters · filed 2023-05-15 | -$24.17M derived: sum of 3 quarters · filed 2023-05-15 | -$29.14M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -$10.66M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | -$16.81M derived: sum of 2 quarters · filed 2023-04-17 | -$21.78M derived: sum of 3 quarters · filed 2023-04-17 | -$25.74M 10-K · filed 2023-04-17 | ||||
| 2021-09-30 | -$6.14M 10-Q · filed 2022-11-14 | -$11.11M derived: sum of 2 quarters · filed 2022-11-14 | -$15.07M 10-Q · filed 2022-11-14 | -$18.63M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$4.97M 10-Q · filed 2022-08-12 | -$8.93M 10-Q · filed 2022-08-12 | -$12.49M derived: sum of 3 quarters · filed 2022-08-12 | -$14.91M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | -$3.96M 10-Q · filed 2022-05-13 | -$7.52M derived: sum of 2 quarters · filed 2022-05-13 | -$9.93M derived: sum of 3 quarters · filed 2022-05-13 | -$21.30M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | -$3.56M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | -$5.98M derived: sum of 2 quarters · filed 2022-04-08 | -$17.34M derived: sum of 3 quarters · filed 2022-04-08 | -$19.20M 10-K · filed 2022-04-08 | ||||
| 2020-09-30 | -$2.42M 10-Q · filed 2022-03-11 | -$13.78M derived: sum of 2 quarters · filed 2022-03-11 | -$15.64M 10-Q · filed 2022-03-11 | -$17.80M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-06-30 | -$11.37M 10-Q · filed 2021-08-13 | -$13.22M 10-Q · filed 2021-08-13 | -$15.39M derived: sum of 3 quarters · filed 2021-08-13 | -$16.27M derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | -$1.85M 10-Q · filed 2021-05-14 | -$4.02M derived: sum of 2 quarters · filed 2021-05-14 | -$4.90M derived: sum of 3 quarters · filed 2021-05-14 | |||||
| 2019-12-31 | -$2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$3.05M derived: sum of 2 quarters · filed 2021-03-31 | -$3.71M 10-K · filed 2021-03-31 | |||||
| 2019-09-30 | -$879.50K 10-Q · filed 2020-11-30 | -$1.54M 10-Q · filed 2020-11-30 |